Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Allianz    ALV   DE0008404005

ALLIANZ (ALV)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

European shares retreat after week of gains; Allianz rallies after update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 11:42am CEST
A plastic bull figurine, symbol of the Frankfurt stock exchange is pictured in front of the German share price index DAX board at the Frankfurt stock exchange

European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

European shares fell on Friday with gains in insurance heavyweight Allianz (>> Allianz SE) and firmer pharma stocks more than offset by a pull-back in banking and mining stocks.

The pan-European STOXX 600 <.STOXX> index fell 0.5 percent but remained close to a 13-month high reached on Wednesday and on track to end higher for the second week in a row.

The rally has been fuelled by strong earnings updates, a pick up in merger and acquisition (M&A) activity, with cyclical stocks such as mining companies and banks lifted by solid economic data.

Allianz rose 2.4 percent. Europe's largest insurer proposed spending 3 billion euros on buying back its own shares after posting higher-than-expected profits and saying it was adjusting its policy on budgeting for possible takeovers.

The Munich-based firm also raised its dividend.

"The combination of a dividend increase and a share buy-back probably both at the upper end of market expectations is a sign of strength and should improve sentiment and provide tailwind for the shares," DZ Bank analyst Thorsten Wenzel said.

Elsewhere in the insurance sector, Dutch insurer Aegon (>> AEGON) rose as much as 4.2 percent as investors cheered to a stronger than expected pretax profit growth. Its shares pared gains and were last up 0.3 percent.

On the M&A front, Stada (>> STADA Arzneimittel AG) was once again in focus after the German generic drugs company said it had received its third takeover approach, valuing the company at 58 euros per share, above its current market value and higher than a previous takeover offer. Its shares rose 1.1 percent.

Some big drugmaker stocks were also in demand, lifting the healthcare index <.SXDP> up slightly and making it the only sectoral gainer in Europe.

Britain's AstraZeneca (>> AstraZeneca plc) and GlaxoSmithKline (>> GlaxoSmithKline plc) were up 1.6 percent and 0.5 percent respectively after analysts at Jefferies raised the price target for both.

Europe's STOXX bank index <.SX7P> fell 1.2 percent as investors booked profits for a second day after the index hit a three-week high on Wednesday, helped by growing expectations of a rate hike next month in the United States.

Deutsche Bank (>> Deutsche Bank AG), Standard Chartered (>> Standard Chartered PLC) and Credit Agricole (>> Crédit Agricole) fell between 2.6 and 2.8 percent.

Miners <.SXDP> were also weaker, down 1.1 percent, pulling back after climbing earlier this week to their highest level in more than two years. Copper slid on Friday because of some profit taking, but the likelihood of strong demand from top consumer China were expected to support prices.

"Short-term technicals remain in overbought territory making rounds of profit-taking...more likely," said Markus Huber, trader at City of London Markets.

Top loser on the STOXX was Vopak (>> Koninklijke Vopak), down 8.7 percent, after the Dutch oil and chemical storage company said it did not expect core profit to grow this year.

(Reporting by Danilo Masoni; Editing by Angus MacSwan)

By Danilo Masoni

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLIANZ
04:42a OLDENBURGISCHE LANDESBANK : Allianz Sells Stake In Oldenburgische Landesbank
06/25 EULER HERMES : As talks begin in brussels, insurer's bleak warning...
06/24 ALLIANZ : Life Awards $42,000 in Scholarships to Area Students
06/24 Allianz sells private bank OLB to Apollo for 300 million euros
06/23 ALLIANZ : sells stake in Oldenburgische Landesbank AG
06/23 DGAP-WPÜG : Takeover Offer;
06/23 ALLIANZ : to cut 700 jobs in Germany in next three years - Sueddeutsche
06/22 ALLIANZ : AGF Orders Appeal against CCT Judgment on Saraki
06/22 Allianz to Sell Insurance in China
06/22 ALLIANZ : Comments On Anti-Graft War - AGF Blasts Sagay, Others
More news
Sector news : Multiline Insurance & Brokers - NEC
06/23 Global reinsurers ask EU for mutual market access with Britain post-Brexit
06/21 ARTHUR J GALLAGHER : Drugmaker Mylan gets boost from unlikely source - coal
06/19 JOHN PAULSON : Billionaire investor Paulson joins Valeant board, shares jump
06/15 Attacks on Western cities prompt insurers to adapt
06/14DJAON : Apprenticeships Aren't Just for Welders Anymore -- 2nd Update
More sector news : Multiline Insurance & Brokers - NEC
News from SeekingAlpha
06/16 Dan Ivascyn leads Pimco back to the top
06/14 New Triple-Digit Dividend Record + Projection Tool For My 74 Stock Portfolio ..
05/31 Allianz SE (ALIZF) Presents At Deutsche Bank Global Financial Services Confer..
05/17 Rush into passive funds slows a bit in April - Morningstar
05/12 Allianz's (AZSEY) CEO Oliver Bäte on Q1 2017 Results - Earnings Call Transcri..
Advertisement
Financials (€)
Sales 2017 116 208 M
EBIT 2017 10 743 M
Net income 2017 7 030 M
Debt 2017 -
Yield 2017 4,56%
P/E ratio 2017 11,02
P/E ratio 2018 10,48
Capi. / Sales 2017 0,68x
Capi. / Sales 2018 0,67x
Capitalization 79 472 M
More Financials
Chart ALLIANZ
Duration : Period :
Allianz Technical Analysis Chart | ALV | DE0008404005 | 4-Traders
Full-screen chart
Technical analysis trends ALLIANZ
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 185 €
Spread / Average Target 6,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Oliver Bäte Chief Executive Officer
Michael Diekmann Chairman-Supervisory Board
Christof Mascher Chief Operating Officer
Dieter Wemmer Chief Financial Officer
Rolf Zimmermann Vice Chairman-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLIANZ10.76%88 874
CHUBB LTD9.64%67 634
AMERICAN INTERNATIONAL..-3.51%58 112
ZURICH INSURANCE GROUP1.50%44 318
MARSH & MCLENNAN COMPA..15.49%40 227
HARTFORD FINANCIAL SER..7.97%18 901
More Results